Factor | Â | All patients | Inflammation | Â | |
---|---|---|---|---|---|
N | (N = 186) | Normal (N = 160) | High (N = 26) | p value | |
Age (years)b | 186 | 66 (59, 73)b | 66 (58, 72) | 70 (60, 73) | 0.225 |
Female gender (%)a | 186 | 144 (77.4%) | 121 (75.6%) | 23 (88.5%) | 0.206 |
Disease duration (years)b | 154 | 16 (11, 25)b | 16 (11,25) | 16 (12. 21) | 0.692 |
RF (%)a | 183 | 136 (74.3%) | 114 (72.2%) | 22 (88.0%) | 0.137 |
Anti-CCP antibodies (%)a | 181 | 115 (63.5%) | 96 (61.5%) | 19 (76.0%) | 0.186 |
ESR (mm/h)b | 181 | 11 (5, 22)b | 9 (5, 16) | 40 (30, 56) | - |
CRP (mg/L)b | 186 | 3.0 (2.9, 8.0)b | 2.9 (2.9, 4.5) | 21.0 (13.0, 31.0) | - |
DAS 28c | 181 | 3.14 (1.18)c | 2.97 (1.10) | 4.19 (1.12) | <0.001 |
ADMA (μmol/L)d | 181 | 0.56 (0.54–0.58)d | 0.55 (0.53–0.57) | 0.59 (0.56–0.63) | 0.136 |
SDMA (μmol/L)d | 186 | 0.46 (0.44–0.47)d | 0.46 (0.45–0.47) | 0.45 (0.41–0.50) | 0.812 |
ADMA:SDMAd | 181 | 1.22 (1.17–1.27)d | 1.20 (1.15–1.25) | 1.30 (1.17–1.46) | 0.167 |
Arterial stiffnessc | 165 | 33 (9)c | 33 (9) | 33 (8) | 0.791 |
Microvascular endothelial dependent (ACh %)d | 179 | 235 (207–265)d | 244 (213–276) | 184 (119–262) | 0.145 |
Microvascular endothelial- independent (SNP %)d | 179 | 116 (100–134)d | 119 (102–138) | 100 (60–159) | 0.421 |
Macrovascular endothelial- dependent (FMD %)d | 173 | 9.8 (8.8–10.8)d | 9.9 (8.8–11.0) | 9.0 (6.4–11.9) | 0.554 |
Macrovascular endothelial- independent (GTN %)d | 155 | 19.6 (18.2–21.1)d | 19.7 (18.2–21.4) | 18.9 (16.0–22.4) | 0.715 |
cIMT (mm)d | 157 | 0.68 (0.66–0.70)d | 0.67 (0.65–0.70) | 0.72 (0.67–0.79) | 0.116 |